GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial
GSK’s seasonal, mRNA-based influenza vaccine is progressing to a Phase III study after securing a safety and efficacy…
GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo Finance
GSK is moving its experimental mRNA-based seasonal flu vaccine into a late-stage trial after mid-stage data showed it…